Overseas advance of pharmaceutical firms and bioventure firms looming

Published: 2002-07-11 07:00:00

Updated: 2002-07-11 07:00:00

Business sources say the overseas advance of the domestic pharmaceutical firms and bioventure firm, which has been actively pushed for the timely development of new drugs in the biotechnology sector, is running into difficulties.

According to business observers, both Korea Health Industry Deve...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK